Does Cefazolin Outperform Clindamycin-Gentamicin for Infection Prevention in Planned Cesarean Delivery?

Pregnancy News

Does Cefazolin Outperform Clindamycin-Gentamicin for Infection Prevention in Planned Cesarean Delivery?
PregnantCesarean DeliveryCaesarean Delivery
  • 📰 Medscape
  • ⏱ Reading Time:
  • 63 sec. here
  • 27 min. at publisher
  • 📊 Quality Score:
  • News: 112%
  • Publisher: 55%

For planned cesarean deliveries, cefazolin showed better infection prevention than clindamycin plus gentamicin.

In planned cesarean deliveries, cefazolin demonstrates superior infection prevention compared with clindamycin plus gentamicin, with significantly lower rates of inpatient antibiotic use and readmissions .

Researchers conducted a retrospective cohort study at a university-affiliated tertiary medical center between 2012 and 2023, including women undergoing planned cesarean delivery. Analysis included 11,246 eligible women with 10,588 receiving cefazolin and 658 receiving clindamycin plus gentamicin because of severe penicillin or cephalosporin allergies. Prophylactic antibiotics were administered within 30 minutes before incision with cefazolin dosing at 2 g and the alternative regimen consisting of clindamycin 600 mg plus gentamycin 5 mg/kg. Primary outcome measures included the need for inpatient antibiotic treatment, and secondary outcomes included readmission for obstetric or gynecologic complications.Infectious complications occurred less frequently in the cefazolin group with inpatient antibiotic treatment rates of 5.9% compared with 15.2% in the clindamycin plus gentamicin group . This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Medscape /  🏆 386. in US

Pregnant Cesarean Delivery Caesarean Delivery Cesarean Section Caesarean Section C-Section Antibiotics Inpatient Care Inpatient Patient Safety Allergy Postoperative Infection Artificial Intelligence Deep Learning AI NPL Machine Learning ML Natural Language Processing Artificial Neural Networks Board Certification Boards Board Recertification Endometritis Hospitals

 

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

2 Stocks That Could Outperform With Earnings in Focus2 Stocks That Could Outperform With Earnings in FocusMarket Analysis by covering: S&P 500, Dow Jones Industrial Average, US Small Cap 2000, SPDR® S&P 500® ETF Trust. Read 's Market Analysis on Investing.com
Read more »

Ether will ‘knock on $4,000’ and soon outperform Bitcoin: NovogratzEther will ‘knock on $4,000’ and soon outperform Bitcoin: NovogratzGalaxy Digital CEO Michael Novogratz told CNBC on Thursday that shrinking ETH supply, combined with growing institutional interest, could position the asset to outperform Bitcoin.
Read more »

Oppenheimer upgrades used-car seller Carvana to outperform as it sees nearly 40% upside aheadOppenheimer upgrades used-car seller Carvana to outperform as it sees nearly 40% upside aheadOppenheimer believes that Carvana could continue growing its market share within the used-car space, further helping drive sales.
Read more »

Bernstein upgrades Charter to outperform on recovering financials, predicts more than 20% upside aheadBernstein upgrades Charter to outperform on recovering financials, predicts more than 20% upside aheadBernstein analyst Lauren Yoon wrote that cable companies 'are far from structurally broken.'
Read more »

Wolfe Research upgrades Texas Instruments to outperform, sees cyclical recovery aheadWolfe Research upgrades Texas Instruments to outperform, sees cyclical recovery aheadWolfe Research sees shares of Texas Instruments rising 24% from here.
Read more »

Dow Jones futures rise on dovish Fed outlook, chip stocks outperformDow Jones futures rise on dovish Fed outlook, chip stocks outperformDow Jones futures advance during early European hours, ahead of the market opening in the United States (US) on Friday, trading above 44,100, up by 0.14%. Meanwhile, S&P 500 futures rise by 0.16% to 6,370, and Nasdaq 100 futures appreciate 0.18% to trade around 23,300.
Read more »



Render Time: 2026-04-01 21:47:39